BioSpace News Archive

Drug Development

Landmark Study: Researchers Cure Lethal Disease in Prenatal Mice Using CRISPR

CRISPR, the gene editing technique that scientists claim will lead to the cure and prevention of countless diseases and disorders, took a big step in that direction. Researchers at Children’s Hospital of Philadelphia (CHOP) used CRISPR to prevent a deadly metabolic disorder in prenatal laboratory animals.

October 9, 2018
·
3 min read
·
Mark Terry
Genetown

Quanterix’ Simoa Technology Powers Record Number of Presentations and Poster Sessions at ECTRIMS 2018

International multiple sclerosis conference features 35 new studies using Simoa technology demonstrating potential of Neurofilament light chain (NfL) as a reliable and sensitive disease biomarker

October 9, 2018
·
4 min read
Business

GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement

GenAhead Bio Incorporated and ERS Genomics Limited announced today a non-exclusive license agreement to provide GenAhead with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents.

October 9, 2018
·
3 min read
Merck KGaA, Darmstadt, Germany Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Care

First presentation of Phase III data for avelumab (plus axitinib) in previously untreated, advanced kidney cancer

October 9, 2018
·
22 min read
BioCapital

SPI Pharma launches Mannogem® XL mannitol, enabling production of difficult-to-compress and problematic formulations

SPI Pharma introduces Mannogem® XL mannitol to the international pharmaceutical market. It is an innovative approach to mannitol, designed to improve the formulation experience and enhance formulation performance.

October 9, 2018
·
2 min read
Deals

Therachon Expands Rare Disease Pipeline with Acquisition of GLyPharma Therapeutic Inc.

Transformational acquisition advances Therachon’s mission to develop best-in-disease therapies

October 9, 2018
·
3 min read
Business

FSD Pharma Begins Construction of Heritage Museum and Flagship Dispensary in Ontario

FSD Pharma Inc. is pleased to announce that construction has commenced of its heritage museum and flagship dispensary at the former Kraft plant in Cobourg, Ontario, headquarters of its wholly-owned subsidiary FV Pharma Inc.

October 9, 2018
·
3 min read
Business

c-LEcta Signs Europe Sales and Distribution Agreement with VWR for DENARASE®

DENARASE® is now available through VWR’s sales channels in Europe

October 9, 2018
·
2 min read
Drug Development

BerGenBio to Present Interim Phase II Clinical, Preclinical and Biomarker Data With Selective AXL Inhibitor Bemcentinib at ESMO

BerGenBio ASA announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II clinical programme with bemcentinib (BGB324)

October 9, 2018
·
5 min read
Job Trends

GB Sciences’ Dr. Andrea Small-Howard Presents Results of GB Sciences’ Novel Pain Formulation Research at UCLA during CannMed 2018

Dr. Small-Howard explains the mechanisms for the treatment of chronic and neuropathic pain using proprietary, cannabis-based formulations

October 9, 2018
·
3 min read